GB8901778D0 - Manipulatory technique - Google Patents

Manipulatory technique

Info

Publication number
GB8901778D0
GB8901778D0 GB898901778A GB8901778A GB8901778D0 GB 8901778 D0 GB8901778 D0 GB 8901778D0 GB 898901778 A GB898901778 A GB 898901778A GB 8901778 A GB8901778 A GB 8901778A GB 8901778 D0 GB8901778 D0 GB 8901778D0
Authority
GB
United Kingdom
Prior art keywords
manipulatory
technique
manipulatory technique
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898901778A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
University of Glasgow
Original Assignee
University of Edinburgh
University of Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh, University of Glasgow filed Critical University of Edinburgh
Priority to GB898901778A priority Critical patent/GB8901778D0/en
Publication of GB8901778D0 publication Critical patent/GB8901778D0/en
Priority to PCT/GB1990/000116 priority patent/WO1990008832A1/en
Priority to CA 2045480 priority patent/CA2045480A1/en
Priority to EP19900902361 priority patent/EP0455695A1/en
Priority to JP50267690A priority patent/JPH04503004A/en
Priority to AU50276/90A priority patent/AU633052B2/en
Priority to GB9001808A priority patent/GB2228487B/en
Priority to NZ23227490A priority patent/NZ232274A/en
Priority to FI913582A priority patent/FI913582A0/en
Pending legal-status Critical Current

Links

GB898901778A 1989-01-27 1989-01-27 Manipulatory technique Pending GB8901778D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB898901778A GB8901778D0 (en) 1989-01-27 1989-01-27 Manipulatory technique
PCT/GB1990/000116 WO1990008832A1 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
CA 2045480 CA2045480A1 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
EP19900902361 EP0455695A1 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
JP50267690A JPH04503004A (en) 1989-01-27 1990-01-26 Retroviral vectors and their use in the production of transgenic animals
AU50276/90A AU633052B2 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
GB9001808A GB2228487B (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
NZ23227490A NZ232274A (en) 1989-01-27 1990-01-29 Retroviral vector comprising the env gene product of feline leukemia virus-b (felv-b) and the gag and pol products of a retrovirus, transgenic sheep and pigs and a method of introducing nucleic acid into an animal embryo
FI913582A FI913582A0 (en) 1989-01-27 1991-07-26 RETROVIRAL VECTOR OCH DESS ANVAENDNING VID MODUCLERING AV TRANSGENA DJUR.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898901778A GB8901778D0 (en) 1989-01-27 1989-01-27 Manipulatory technique

Publications (1)

Publication Number Publication Date
GB8901778D0 true GB8901778D0 (en) 1989-03-15

Family

ID=10650690

Family Applications (2)

Application Number Title Priority Date Filing Date
GB898901778A Pending GB8901778D0 (en) 1989-01-27 1989-01-27 Manipulatory technique
GB9001808A Expired - Lifetime GB2228487B (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9001808A Expired - Lifetime GB2228487B (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals

Country Status (8)

Country Link
EP (1) EP0455695A1 (en)
JP (1) JPH04503004A (en)
AU (1) AU633052B2 (en)
CA (1) CA2045480A1 (en)
FI (1) FI913582A0 (en)
GB (2) GB8901778D0 (en)
NZ (1) NZ232274A (en)
WO (1) WO1990008832A1 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2138553C1 (en) * 1991-09-30 1999-09-27 Берингер Ингельгейм Интернациональ ГмбХ Transfection composition for higher eucaryotic cells, nucleic acid complex useful as component of transfection composition, conjugate useful as component of transfection composition, endosomolytic peptide useful as component of transfection composition
AU2146092A (en) * 1992-05-28 1993-12-30 Scientific Dimensions Usa, Inc. Transgenic animal production with biolistically transformed spermatozoa
GB2269175A (en) * 1992-07-31 1994-02-02 Imperial College Retroviral vectors
WO1994006921A1 (en) * 1992-09-21 1994-03-31 Viagene, Inc. Recombinant retroviral vector against felv and/or fiv
US6013517A (en) * 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
ES2297831T3 (en) 1994-05-09 2008-05-01 Oxford Biomedica (Uk) Limited RETROVIRIC VECTORS THAT PRESENT A REDUCED RECOMBINATION RATE.
US6066778A (en) * 1996-11-06 2000-05-23 The Regents Of The University Of Michigan Transgenic mice expressing APC resistant factor V
US6080910A (en) * 1997-02-20 2000-06-27 Case Western Reserve University Transgenic knockout animals lacking IgG3
DE69838789T2 (en) 1997-03-12 2008-10-30 Suzanne Cambridge de la Monte METHOD FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE
US6080912A (en) * 1997-03-20 2000-06-27 Wisconsin Alumni Research Foundation Methods for creating transgenic animals
US6080911A (en) * 1997-04-15 2000-06-27 Ohio University Mice models of growth hormone insensitivity
US6787319B2 (en) 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6060310A (en) * 1997-11-24 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Transcription factor decoy and tumor growth inhibitor
US6500637B1 (en) 1998-03-31 2002-12-31 The Institute Of Physical And Chemical Research Neurogenesis inducing genes
US6225456B1 (en) 1998-05-07 2001-05-01 University Technololy Corporation Ras suppressor SUR-5
US6506889B1 (en) 1998-05-19 2003-01-14 University Technology Corporation Ras suppressor SUR-8 and related compositions and methods
EP1130960A4 (en) * 1998-11-19 2003-07-30 Wisconsin Alumni Res Found Transgenic animals
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US6759525B2 (en) 2000-08-25 2004-07-06 The United States Of America As Represented By The Department Of Health And Human Services Protein kinase A and carney complex
US7060442B2 (en) 2000-10-30 2006-06-13 Regents Of The University Of Michigan Modulators on Nod2 signaling
US6849449B2 (en) 2001-03-01 2005-02-01 Regents Of The University Of Michigan Orphanin FQ receptor nucleic acids
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
KR20030022094A (en) 2001-05-24 2003-03-15 (주)휴먼디엔에이테크놀로지 Novel keratinocyte growth factor-2 analogue in hair follicle
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
AU2002336517B2 (en) * 2001-09-13 2008-09-11 California Institute Of Technology Method for producing transgenic animals
US7108975B2 (en) 2001-09-21 2006-09-19 Regents Of The University Of Michigan Atlastin
US7582425B2 (en) 2001-09-21 2009-09-01 The Regents Of The University Of Michigan Atlastin
US20030165954A1 (en) 2002-01-09 2003-09-04 Third Wave Technologies, Inc. Cancer profiles
US7255986B2 (en) 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
WO2004020454A2 (en) 2002-08-30 2004-03-11 Biorexis Pharmaceutical Corporation Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
US7173010B2 (en) 2003-05-19 2007-02-06 Regents Of The University Of Michigan Orphanin FQ receptor
AU2004256425A1 (en) 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7432057B2 (en) 2004-01-30 2008-10-07 Michigan State University Genetic test for PSE-susceptible turkeys
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
CN101087879B (en) 2004-06-18 2013-08-14 杜克大学 Modulators of odorant receptors
EP1880024A4 (en) 2005-05-12 2009-12-09 Third Wave Tech Inc Polymorphic ghsr nucleic acids and uses thereof
AU2006259583A1 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CA2814598A1 (en) 2005-09-12 2007-03-22 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
TW200732347A (en) 2005-10-06 2007-09-01 Trophogen Inc VEGF analogs and methods of use
US7794951B2 (en) 2005-10-18 2010-09-14 University Of Massachusetts Medical School SREBP2gc transcription factors and uses thereof
DK2500360T3 (en) 2005-10-31 2015-10-26 Oncomed Pharm Inc Compositions and methods for the diagnosis and treatment of cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
US9277737B2 (en) 2006-09-21 2016-03-08 Probiodrug Ag Mouse models carrying a knock-out mutation of the QPCTL-gene
ES2372229T3 (en) 2007-01-19 2012-01-17 Probiodrug Ag IN VIVO SELECTION MODELS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER QPCT-RELATED DISORDERS.
EP2106439B1 (en) 2007-01-24 2014-11-12 The Regents of the University of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
PT2173379E (en) 2007-07-02 2015-11-24 Oncomed Pharm Inc Compositions and methods for treating and diagnosing cancer
AU2008275303B2 (en) 2007-07-06 2012-05-03 The Regents Of The University Of Michigan MIPOL1-ETV1 gene rearrangements
EP3018216B1 (en) 2007-07-06 2018-09-12 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US20090047269A1 (en) 2007-08-16 2009-02-19 The Regents Of The University Of Michigan Metabolomic cancer targets
US8283517B2 (en) 2007-09-12 2012-10-09 Probiodrug Ag Transgenic mouse models of Aβ overexpression
NZ586665A (en) 2008-01-14 2011-12-22 Probiodrug Ag MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE GLUTAMINYL CYCLASE GENE (Qpct)
AU2008349175B2 (en) 2008-01-29 2014-01-30 Keio University Method for introducing foreign gene into early embryo of primate animal and method of producing transgenic primate animal comprising such method
CN105079805A (en) 2008-09-26 2015-11-25 昂考梅德药品有限公司 Frizzled-binding agents and uses thereof
CN102639709A (en) 2009-01-09 2012-08-15 密歇根大学董事会 Recurrent gene fusions in cancer
TWI535445B (en) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt antagonists and methods of treatment and screening
US20110237461A1 (en) 2010-03-17 2011-09-29 The Regents Of The University Of Michigan Using phage epitopes to profile the immune response
EP2552953B1 (en) 2010-04-01 2017-05-17 OncoMed Pharmaceuticals, Inc. Frizzled-binding agents and uses thereof
WO2012028706A1 (en) 2010-09-02 2012-03-08 Probiodrug Ag IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
EP2690950B1 (en) 2011-03-29 2017-01-04 Dynavax Technologies Corporation Tlr8 transgenic animals
US20130052203A1 (en) 2011-08-12 2013-02-28 Probiodrug Ag In vivo screening models for treatment of qc-related disorders
WO2013053765A1 (en) 2011-10-11 2013-04-18 Proyecto De Biomedicina Cima, S.L. A non-human animal model of mucosa-associated lymphoid tissue (malt) lymphoma
WO2013165613A1 (en) 2012-05-02 2013-11-07 New York University Methods of treating and preventing staphylococcus aureus infections and associated conditions
US10457713B2 (en) 2012-07-30 2019-10-29 Trophogen, Inc. Glycoprotein hormone long-acting superagonists
CN112409472A (en) 2012-07-30 2021-02-26 特洛佛根股份有限公司 Long-acting superagonists of glycoprotein hormones
US9266959B2 (en) 2012-10-23 2016-02-23 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using frizzled-binding agents
JP2016510411A (en) 2013-02-04 2016-04-07 オンコメッド ファーマシューティカルズ インコーポレイテッド Methods and monitoring of treatment with WNT pathway inhibitors
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
EP3610724A1 (en) 2013-09-12 2020-02-19 Icahn School of Medicine at Mount Sinai T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated t cells, and methods of use
JP2017502079A (en) 2013-11-05 2017-01-19 トロフォジェン インコーポレイテッド Glycoprotein hormone long acting super agonist
DE102016221219A1 (en) 2016-10-27 2018-05-03 Schaeffler Technologies AG & Co. KG Method and plant for producing a friction lining made of sintered metal
WO2022235929A1 (en) 2021-05-05 2022-11-10 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
US20220403397A1 (en) 2021-06-10 2022-12-22 Janssen Biotech, Inc. Nucleic acid constructs encoding kallikrein-2 fusion protein and vectors, preparations of cells, and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63501923A (en) * 1985-12-05 1988-08-04 フレツド　ハツチンソン　キヤンサ−　リサ−チ　センタ− Antisense RNA for the treatment of retroviral disease conditions
ATE142268T1 (en) * 1988-05-17 1996-09-15 Sloan Kettering Inst Cancer RETROVIRAL VECTOR
CA2005311C (en) * 1988-12-13 2006-05-30 Edward A. Hoover Prototype felv isolates for use in disease models and vaccines

Also Published As

Publication number Publication date
GB2228487B (en) 1992-09-09
GB2228487A (en) 1990-08-29
JPH04503004A (en) 1992-06-04
NZ232274A (en) 1992-09-25
AU633052B2 (en) 1993-01-21
WO1990008832A1 (en) 1990-08-09
GB9001808D0 (en) 1990-03-28
AU5027690A (en) 1990-08-24
CA2045480A1 (en) 1990-07-28
FI913582A0 (en) 1991-07-26
EP0455695A1 (en) 1991-11-13

Similar Documents

Publication Publication Date Title
GB8901778D0 (en) Manipulatory technique
DE4090310D2 (en) Teleskopkrone
AU108277S (en) Hedge-shears
DE3991623D2 (en) Frequenzueberwachungsanordnung
CS9005442A2 (en) Symmetrizer
CS490790A3 (en) Chaff-cutter
DE4090110D2 (en) Rotationskolbenverbrennungskraftmaschine
DE4091364D2 (en) Thermosaeulen-strahlungsdetektor
DE4091275D2 (en) Steppdecke
GB9005159D0 (en) Container-loading devices
BG49771A1 (en) Electric- bow evaparator
GB2236998B (en) Non-refill devices
DE4090763D2 (en) Abfallsammler
DE4090235D2 (en) Hauptabsperrventil
DE3991687D2 (en) Dufttresor
DE3991686D2 (en) Schmuckblende
DE4091102D2 (en) Spundlochverschluss
GB8923698D0 (en) Non-refilling devices
CA64817S (en) Liminaire
CA64838S (en) Automibile
CA64463S (en) Tapeplayer
DE3991146D2 (en) Schraubverschluss
IE890646L (en) Solid eledtrolyte devices
GB8929037D0 (en) Devices
GB8920751D0 (en) Devices